As 2025 closes, we reflect on key lessons shaping advanced therapy manufacturing and share five trends expected to define pharma and CDMOs in 2026.

As developers and occupiers plan for 2026, early engagement with design-build partners like Inuti is key to faster, smoother, and more compliant science projects.

As COP and year-end sustainability reviews approach, discover how Inuti helps developers create Net Zero-ready laboratories designed for performance and compliance.

As 2025 draws to a close, developers are turning to adaptive reuse to meet surging life science demand in 2026. Discover why reusing existing buildings makes both commercial and environmental sense.